Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
TransMedics Group Inc | TMDX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
89.25 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 36.4201 - 99.63 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 89.25 | USD |
TransMedics (TMDX) Options Flow Summary
TransMedics Group Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.92B | 32.72M | - | 241.62M | -25.03M | -0.77 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
TransMedics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TMDX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 86.68 | 90.9695 | 82.87 | 87.36 | 626,353 | 2.57 | 2.96% |
1 Month | 74.01 | 97.78 | 70.34 | 86.92 | 843,761 | 15.24 | 20.59% |
3 Months | 86.53 | 97.78 | 69.43 | 83.53 | 771,813 | 2.72 | 3.14% |
6 Months | 39.89 | 97.78 | 36.4201 | 74.89 | 728,504 | 49.36 | 123.74% |
1 Year | 83.28 | 99.63 | 36.4201 | 71.43 | 714,507 | 5.97 | 7.17% |
3 Years | 28.64 | 99.63 | 10.00 | 57.98 | 459,615 | 60.61 | 211.63% |
5 Years | 22.10 | 99.63 | 10.00 | 49.32 | 378,972 | 67.15 | 303.85% |
TransMedics Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body. |